1. Moкpышeвa, H., et al., Анализ основных эпидемиологических характеристик первичного гunepnapamupeoзa в России (по данным регистра). Проблемы эндокринологии, 2012. S8(S).
2. Bilezikian, J.P., et al., Primary hyperparathyroidism. Nature reviews Disease primers, 2016. 2: p. 16033.
3. Walker, M.D. and J.P. Bilezikian, Vitamin D and primary hyperparathyroidism: more insights into a complex relationship. 2017, Springer.
4. Cromer, M.K., et al., Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. The Journal of Clinical Endocrinology & Metabolism, 2012. 97(9): p. E1774-E1781.
5. Thakker, R., Genetics of parathyroid tumours. Journal of internal medicine, 2016. 280(6): p. 574-583.
6. Bricaire, L., et al., Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism, 2013. 98(2): p. E403-E408.
7. Warner, J., et al., Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. Journal of Medical Genetics, 2004.41(3): p. 155-160.
8. Yu, W., et al., Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. The Journal of Clinical Endocrinology & Metabolism, 2015.100(2): p. E360-E364.
9. Wermers, R.A., et al., The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Annals of Internal Medicine, 1997. 126(6): p. 433-440.
10. Khan, A.A., et al., Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int, 2017. 28(1):p.l-19.
11. Clarke, B.L., Asymptomatic Primary Hyperparathyroidism, in Parathyroid Disorders. 2019, Karger Publishers, p. 13-22.
12. Christensson, T., et al., Prevalence of hypercalcaemia in a health screening in Stockholm. Acta Medica Scandinavica, 1976. 200(1-6): p. 131-137.
13. Palmer, M., et al.,Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values. European journal of clinical investigation, 1988.18(1): p. 39-46.
14. Yu, N., et al., Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clinical endocrinology, 2009. 71(4): p. 485-493.
15. Siilin, H., et al., Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World journal of surgery, 2011. 35(6): p. 1266-1272.
16. Yeh, M.W., et al., Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. The Journal of Clinical Endocrinology & Metabolism, 2013.98(3): p. 1122-1129.
17. Cusano, N.E., et al., Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. The Journal of Clinical Endocrinology & Metabolism, 2013. 98(7): p. 2734-2741.
18. Rubin, M.R., et al., The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. The Journal of Clinical Endocrinology & Metabolism, 2008. 93(9): p. 3462-3470.
19. Silverberg, S.J., et al., A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England Journal of Medicine, 1999. 341(17): p. 1249-1255.
20. Vestergaard, P., et al., Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg, 2003. 27(2): p. 216-22.
21. Bopoнeнкo, И., et al., Состояние сердечно-сосудистой системы при клинически выраженном и мaлocuмnmoмнoм первичном гunepnapamupeoзe. Проблемы эндокринологии, 2009. 3: р. 17-22.
22. Vestergaard, P. and L. Mosekilde, Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ, 2003. 327(7414): p. 530-4.
23. Thomas, A. and A. Kautzky-Willer, Diabetes in hyperparathyroidism, in Diabetes Secondary to Endocrine and Pancreatic Disorders. 2014, Karger Publishers, p. 92-100.
24. Procopio, M., et al., Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine, 2014.47(2): p. 581-9.
25. Mendoza-Zubieta, V., et al., High prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT). BMC endocrine disorders, 2015. 15(1): p. 16.
26. Christensen, S.E., et al., Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clinical endocrinology, 2008. 69(5): p. 713-720.
27. Nordenstrom, E., P. Katzman, and A. Bergenfelz, Biochemical diagnosis of primary hyperparathyroidism: analysis of the sensitivity of total and ionized calcium in combination with PTH. Clinical biochemistry, 2011.44(10-11): p. 849-852.
28. Amin, A.L., et al., Normal PTH levels in primary hyperparathyroidism: still the same disease? Annals of surgical oncology, 2011.18(12): p. 3437-3442.
29. Monchik, J.M. and E. Gorgun, Normocalcemic hyperparathyroidism in patients with osteoporosis. Surgery, 2004.136(6): p. 1242-1246.
30. Lowe, H., et al., Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. The Journal of Clinical Endocrinology & Metabolism, 2007. 92(8): p. 3001-3005.